Trial Profile
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Oct 2020
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Systemic lupus erythematosus
- Focus Biomarker; Therapeutic Use
- 17 Jan 2012 New trial record